Mirum Pharmaceuticals stockMIRM
Mirum Pharmaceuticals trades at $93.54, 28.0% below its 52-week high (Jul 9, 2026). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. +18.4% year to date, +33.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 10, 2027.
Ratings, candles, signals and the screener for MIRM — after you log in
Open the terminalFrequently asked questions about Mirum Pharmaceuticals
What is the Mirum Pharmaceuticals stock price?
At the close on Nov 5, 2026: $93.54 (−3.54% on the day). 52-week high: $130.00 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Mirum Pharmaceuticals report earnings?
The next quarterly report is on Mar 10, 2027. Last quarter, earnings per share changed −1,840% year over year, revenue +40%.
Does Mirum Pharmaceuticals pay dividends?
No, Mirum Pharmaceuticals does not pay dividends.
Where does Mirum Pharmaceuticals trade and how to buy it?
Ticker MIRM, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Mirum Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for MIRM are in the terminal after you log in.